HSBC Holdings’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-77,184
Closed -$384K 2861
2025
Q2
$384K Buy
+77,184
New +$335K ﹤0.01% 2299
2023
Q2
Sell
-19,053
Closed -$119K 2633
2023
Q1
$119K Buy
+19,053
New +$106K ﹤0.01% 2484
2022
Q1
Sell
-6,878
Closed -$226K 3330
2021
Q4
$226K Buy
+6,878
New +$277K ﹤0.01% 2971
2021
Q3
Sell
-9,609
Closed -$348K 3045
2021
Q2
$348K Sell
9,609
-6,890
-42% -$254K ﹤0.01% 2415
2021
Q1
$643K Buy
16,499
+9,443
+134% +$425K ﹤0.01% 1834
2020
Q4
$284K Buy
+7,056
New +$324K ﹤0.01% 2603

Other funds holding GDRX

HSBC Holdings's GDRX Position: Q3 2025 in Review

HSBC Holdings sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 77,184 shares — an estimated $384K sold.

HSBC Holdings first reported a position in GDRX in Q4 2020 and held it in 6 quarters. The position peaked at $643K in Q1 2021. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • HSBC Holdings reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 77,184 GoodRx Holdings shares in Q3 2025, an estimated $384K.
  • HSBC Holdings first reported a position in GoodRx Holdings in Q4 2020 and held it in 6 quarters.
  • HSBC Holdings's GoodRx Holdings position peaked at $643K in Q1 2021.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.